Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.
Biochim Biophys Acta
; 1833(12): 3054-3063, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-23994619
Palavras-chave
AMLs; BRPF; C-terminal domain of the RNA-polymerase II; CPSF100; CTD-RNA-PolII; EAF6; Esa1-associated factor 6 ortholog; HAT; HMT; HOX; HOXA9; HSF1; ING5; MLL; MOZ; MOZ/YBF2/SAS2/TIP60 homology domain; MYST; PHD; RUNX1; Spi-1/PU.1; Symplekin; Transcription regulation; acute myeloid leukemias; bromodomain and PHD finger-containing protein; cleavage and polyadenylation specificity factor 100; heat shock factor 1; histone acetyltransferase; histone methyltransferase; homeobox; inhibitor of growth 5; mixed lineage leukemia; monocytic leukemia zinc finger; plant homeodomain; runt-related transcription factor 1; spleen focus forming virus proviral integration oncogene/purine-rich box-1
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Proteínas Nucleares
/
Proteínas de Homeodomínio
/
Fatores de Poliadenilação e Clivagem de mRNA
/
Histona Acetiltransferases
/
Proteína de Leucina Linfoide-Mieloide
/
Sistema Hematopoético
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Biochim Biophys Acta
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
França